文献速递血液透析通路

鼻烟窝或VasQ外支撑装置建立的桡头动静脉瘘远期结局

Long-term outcomes of radiocephalic arteriovenous fistulas created in anatomical snuffbox or with VasQ external support device.
PubMed 文献 · J Vasc Surg · 2025-06-04

单中心回顾性分析394例晚期肾病患者的前臂桡头动静脉瘘,比较鼻烟窝(SB-AVF)与VasQ外支撑装置(ES-RCAVF)的远期结局。ES-RCAVF的4周成熟率、成功穿刺率更高,但两组近吻合口狭窄率和5年通畅率无显著差异。VasQ显著增加成熟和穿刺成功概率,女性和糖尿病降低4周成熟概率。

要点

  • 两组近吻合口狭窄率(34% vs 32%)和5年通畅率无显著差异。

核心结论

  • ES-RCAVF短期和长期结局优于SB-AVF,但SB-AVF仍是特定患者保留远端穿刺部位的选项。

临床怎么用

  • ES-RCAVF可提高4周成熟率和成功穿刺率,VasQ显著增加成熟概率。
  • SB-AVF可用于年轻、非糖尿病患者以保留远端血管资源。

局限性

  • 原文未述局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: This study evaluates the long-term outcomes of radiocephalic arteriovenous fistulas (RCAVFs) created in the anatomical snuffbox (SB-AVF) or with the VasQ external support device (ES-RCAVF). METHODS: We conducted a single-center retrospective analysis including 394 primary AVFs created for hemodialysis access in patients with advanced kidney disease between November 2017 and October 2024. Outcomes examined included rates of access maturation, successful cannulation, patency (primary, assisted primary, and secondary), reintervention rates, and rates of juxta-anastomotic stenosis. Multivariate analyses were used to study the associations between baseline characteristics and clinical outcomes, aiming to identify variables that could inform algorithmic decision-making for optimal distal RCAVF configuration selection. RESULTS: The cohort consisted of 148 SB-AVFs and 246 ES-RCAVFs. ES-RCAVFs had significantly higher rates of 4-week maturation (81.9% vs 69.7%; P = .009), successful cannulation (82.6% vs 71.6%; P = .044), and tunneled dialysis catheter (TDC) removal (62.9% vs 56.9%; P = .28) at 6 months as compared with SB-AVFs. There was no significant difference in juxta-anastomotic stenosis rates (34% in the SB-group and 32% in the ES-group; P = .734) or 5-year patency rates between the two groups (26.1% vs 26.6% for primary [P = .531]; 51.2% vs 52.4% for assisted primary [P = .778]; and 56.5% vs 57.8% for secondary [P = .1278] patency rates) for the SB-AVF vs ES-RCAVFs, respectively. The number of interventions per patient year was 0.46 for SB-AVFs and 0.57 for ES-RCAVFs (P = .998). In the multivariate analysis, the VasQ significantly (P = .001) increased the probability of maturation, and female gender (P = .007) and diabetes (P = .026) significantly reduced that probability at 4 weeks. The VasQ also significantly increased the probability of overall maturation (P = .002). Female gender (P = .003) and older age (P = .028) negatively contributed to the probability of overall maturation. Moreover, VasQ significantly increased the probability of cannulation success (P = .034) and was the only significant factor for increased likelihood of TDC removal by 6 months (P = .031). Female gender (P = .002) and older age (P = .006) were associated with a significantly decreased likelihood of TDC removal. CONCLUSIONS: Our findings indicated that, although ES-RCAVFs achieve superior short-term and long-term outcomes, SB-AVFs remain a valuable option for select patients-particularly younger and nondiabetic individuals-to preserve distal access sites for future use.

来源:J Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Shahverdyan R, Hussain MA. Long-term outcomes of radiocephalic arteriovenous fistulas created in anatomical snuffbox or with VasQ external support device. J Vasc Surg. 2025. PMID: 40464722. doi:10.1016/j.jvs.2025.03.166

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。